Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China flag China · Delayed Price · Currency is CNY
8.53
-0.73 (-7.88%)
Sep 10, 2026, 1:15 PM CST

SHE:002349 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,4771,4461,3881,4961,5501,336
Other Revenue
6.7313.8513.6315.4122.5821.41
1,4831,4601,4021,5121,5731,358
Revenue Growth
4.96%4.13%-7.25%-3.90%15.85%5.97%
Cost of Revenue
714.97713.15719.73781.18847.06739.21
Gross Profit
768.34746.8682.36730.58726618.66
Selling, General & Admin
384.96394.33366.72346.78401.01352.64
Research & Development
66.3564.9961.7964.6286.9874.76
Other Operating Expenses
20.320.0417.4817.7722.3920.17
Operating Expenses
471.26479.82449.36431.89514.64462.16
Operating Income
297.07266.98233298.69211.36156.51
Interest Expense
-0.11-0.57-1.34-2.57-6.79-12.94
Interest & Investment Income
17.7130.348.3823.8739.7114.16
Currency Exchange Gain (Loss)
-2.08-2.552.342.356.86-1.48
Other Non Operating Income (Expenses)
3.51-0.21-0.30.43-1.241.45
EBT Excluding Unusual Items
316.11293.96282.09322.76249.9157.7
Gain (Loss) on Sale of Investments
4.914.173.826.834.9931.44
Gain (Loss) on Sale of Assets
-0.03-0.01-0.2-0.09-0.06-0.58
Asset Writedown
-5.38-1.14-2.13-4.52-16.96-16.7
Other Unusual Items
5.656.629.754.7112.347.03
Pretax Income
321.26303.61293.32329.7250.21178.89
Income Tax Expense
45.8641.7745.8553.2337.9238.93
Earnings From Continuing Operations
275.4261.84247.47276.47212.29139.96
Minority Interest in Earnings
-50.63-42.55-34.81-28.77-0.0620.74
Net Income
224.77219.28212.65247.7212.23160.7
Net Income to Common
224.77219.28212.65247.7212.23160.7
Net Income Growth
8.13%3.12%-14.15%16.71%32.06%44.79%
Shares Outstanding (Basic)
819819814814814814
Shares Outstanding (Diluted)
821819814814814814
Shares Change
0.85%0.58%-0.01%0.02%-0.00%-0.03%
EPS (Basic)
0.270.270.260.300.260.20
EPS (Diluted)
0.270.270.260.300.260.20
EPS Growth
7.22%2.53%-14.13%16.69%32.07%44.83%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
298.29320.54280.1262.93296.8225.02
Free Cash Flow Per Share
0.360.390.340.320.360.28
Dividend Per Share
0.0900.0900.0800.0920.0800.060
Dividend Growth
12.50%12.50%-13.04%15.00%33.33%46.34%
Gross Margin
51.80%51.15%48.67%48.33%46.15%45.56%
Operating Margin
20.03%18.29%16.62%19.76%13.44%11.53%
Profit Margin
15.15%15.02%15.17%16.38%13.49%11.83%
Free Cash Flow Margin
20.11%21.96%19.98%17.39%18.87%16.57%
EBITDA
375.75346.42308.14382.89319.43257.8
EBITDA Margin
25.33%23.73%21.98%25.33%20.31%18.99%
D&A For EBITDA
78.6779.4375.1484.21108.07101.29
EBIT
297.07266.98233298.69211.36156.51
EBIT Margin
20.03%18.29%16.62%19.76%13.44%11.53%
Effective Tax Rate
14.28%13.76%15.63%16.14%15.16%21.76%
Revenue as Reported
728.541,4601,4021,5121,5731,358
Advertising Expenses
-9.3113.6913.657.2711.6